Skip to main content
Clinical Trials/CTRI/2022/10/046469
CTRI/2022/10/046469Not yet recruitingPhase 2/3

A Randomized Controlled Clinical Trial Of Jalaukavacharan and Amoxicillin 500mg and Clavulanic acid 125mg In Puyalas With Special Reference to Acute Dacryocystitis

Vidarbha Ayurved Mahavidyalaya Amravati1 site in 1 country60 target enrollmentStarted: October 20, 2022Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Uttamupashaya- 75-100%

Study Overview

Brief Summary

Randomized clinical trial will be conducted to study the effect of Jalaukavcharan in Puyalasa with special referance to Acute dcryocystitis. Trial will be conducted in our institute. Total 60 patients with inclusive criteria having sign and symptomps of Puyalasa will be selected and will be divided in two groups. One group will be advised Jalaukavcharan and other will be advised Amoxicillin 500mg and Clavulanic acid 125 mg.And result will be compared. Primary outcome will be about Evaluation of Puyalasa and secondary outcome will be about assesssment criteria of effect of Jalaukavcharan. And results will be noted.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Open Label

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1 Patients having classical sign and symptoms of Puyalasa 2 patient will be selected irrespective of sex religion occupation.

Exclusion Criteria

  • 1 Patient with congenital Dacryocystitis 2 Patient with other occular disease 3 Recently operated patients 4 Patients with other systemic disorder like DM HTN.

Outcomes

Primary Outcomes

Uttamupashaya- 75-100%

Time Frame: 0th day | 3rd day | 5th day | 15th day | 30th day | 60th day | 90th day

Alpaupashaya- 25-49%

Time Frame: 0th day | 3rd day | 5th day | 15th day | 30th day | 60th day | 90th day

Anupashaya- less than 25%

Time Frame: 0th day | 3rd day | 5th day | 15th day | 30th day | 60th day | 90th day

Madhyanupashaya- 50-74%

Time Frame: 0th day | 3rd day | 5th day | 15th day | 30th day | 60th day | 90th day

Secondary Outcomes

  • Remission in symptoms of Epiphora(Remission in redness at medial canthus)

Investigators

Sponsor
Vidarbha Ayurved Mahavidyalaya Amravati
Sponsor Class
Other [(self)]

Study Sites (1)

Loading locations...

Similar Trials